REBECCA IZRAILOVA: Open Payments
NPI 1114679024 · REGO PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $355 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $128 |
| Celltrion USA Inc. | 2 | $62 |
| QOL Medical, LLC | 2 | $53 |
| Ardelyx, Inc. | 1 | $32 |
| ABBVIE INC. | 1 | $26 |
| Novo Nordisk Inc | 1 | $22 |
| Amgen Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: REZDIFFRA, VEGZELMA, Sucraid, IBSRELA, RINVOQ, Wegovy, ZENPEP.
Industry payments across NY — which companies pay providers there.
